Literature DB >> 11120994

Identification of an erm(A) erythromycin resistance methylase gene in Streptococcus pneumoniae isolated in Greece.

G A Syrogiannopoulos1, I N Grivea, A Tait-Kamradt, G D Katopodis, N G Beratis, J Sutcliffe, P C Appelbaum, T A Davies.   

Abstract

In a serotype 11A clone of erythromycin-resistant pneumococci isolated from young Greek carriers, we identified the nucleotide sequence of erm(A), a methylase gene previously described as erm(TR) in Streptococcus pyogenes. The erm(A) pneumococci were resistant to 14- and 15-member macrolides, inducibly resistant to clindamycin, and susceptible to streptogramin B. To our knowledge, this is the first identification of resistance to erythromycin in S. pneumoniae attributed solely to the carriage of the erm(A) gene.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11120994      PMCID： PMC90289          DOI： 10.1128/AAC.45.1.342-344.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  23 in total

Review 1.  Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants.

Authors:  M C Roberts; J Sutcliffe; P Courvalin; L B Jensen; J Rood; H Seppala
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

2.  Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada.

Authors:  J C De Azavedo; R H Yeung; D J Bast; C L Duncan; S B Borgia; D E Low
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

3.  Carriage of antibiotic-resistant Streptococcus pneumoniae in Greek infants and toddlers.

Authors:  G A Syrogiannopoulos; I N Grivea; G D Katopodis; P Geslin; M R Jacobs; N G Beratis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-04       Impact factor: 3.267

4.  Comparative in vitro activities of linezolid, quinupristin-dalfopristin, moxifloxacin, and trovafloxacin against erythromycin-susceptible and -resistant streptococci.

Authors:  C Betriu; M Redondo; M L Palau; A Sánchez; M Gómez; E Culebras; A Boloix; J J Picazo
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

5.  Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage.

Authors:  A Tait-Kamradt; T Davies; M Cronan; M R Jacobs; P C Appelbaum; J Sutcliffe
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

6.  Antimicrobial use and colonization with erythromycin-resistant Streptococcus pneumoniae in Greece during the first 2 years of life.

Authors:  G A Syrogiannopoulos; I N Grivea; T A Davies; G D Katopodis; P C Appelbaum; N G Beratis
Journal:  Clin Infect Dis       Date:  2000-10-25       Impact factor: 9.079

7.  Resistance to macrolides in Streptococcus pyogenes in France in pediatric patients.

Authors:  E Bingen; F Fitoussi; C Doit; R Cohen; A Tanna; R George; C Loukil; N Brahimi; I Le Thomas; D Deforche
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

8.  Novel mechanism of macrolide resistance in Streptococcus pneumoniae.

Authors:  V D Shortridge; R K Flamm; N Ramer; J Beyer; S K Tanaka
Journal:  Diagn Microbiol Infect Dis       Date:  1996-10       Impact factor: 2.803

9.  Detection of erythromycin-resistant determinants by PCR.

Authors:  J Sutcliffe; T Grebe; A Tait-Kamradt; L Wondrack
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

10.  Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system.

Authors:  J Sutcliffe; A Tait-Kamradt; L Wondrack
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191
View more
  25 in total

1.  Differentiation of resistance phenotypes among erythromycin-resistant Pneumococci.

Authors:  M P Montanari; M Mingoia; E Giovanetti; P E Varaldo
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

2.  Resistance to macrolides and related antibiotics in Streptococcus pneumoniae.

Authors:  Roland Leclercq; Patrice Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

3.  Phenotypes and genotypes of erythromycin-resistant pneumococci in Italy.

Authors:  Maria Pia Montanari; Marina Mingoia; Ileana Cochetti; Pietro Emanuele Varaldo
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

4.  Phenotypic and molecular characterization of tetracycline- and erythromycin-resistant strains of Streptococcus pneumoniae.

Authors:  Maria P Montanari; Ileana Cochetti; Marina Mingoia; Pietro E Varaldo
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

5.  Resistance phenotypes and genotypes of erythromycin-resistant Streptococcus pneumoniae isolates in Beijing and Shenyang, China.

Authors:  Zhao Tiemei; Fang Xiangqun; Liu Youning
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

6.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

7.  Heterogeneous macrolide resistance and gene conversion in the pneumococcus.

Authors:  Nicole Wolter; Anthony M Smith; David J Farrell; Keith P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

8.  Predominance of 23S rRNA mutants among non-erm, non-mef macrolide-resistant clinical isolates of Streptococcus pneumoniae collected in the United States in 1999-2000.

Authors:  Todd A Davies; Karen Bush; Daniel Sahm; Alan Evangelista
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

9.  Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S. pyogenes.

Authors:  K Nagai; T A Davies; L M Ednie; A Bryskier; E Palavecino; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

Review 10.  Multidrug-resistant Streptococcus pneumoniae infections: current and future therapeutic options.

Authors:  Françoise Van Bambeke; René R Reinert; Peter C Appelbaum; Paul M Tulkens; Willy E Peetermans
Journal:  Drugs       Date:  2007       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.